Target Name: LOC105376627
NCBI ID: G105376627
Review Report on LOC105376627 Target / Biomarker Content of Review Report on LOC105376627 Target / Biomarker
LOC105376627
Other Name(s): LOC105376627 variant X3 | Uncharacterized LOC105376627, transcript variant X3 | uncharacterized LOC105376627

LOC105376627: A Potential Drug Target for Neurodegenerative Disorders

LOC105376627, also known as LOC105376627 variant X3, is a protein that is expressed in a variety of tissues and cells in the human body. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to an increase in temperature.

HSPs are involved in a variety of cellular processes, including the regulation of protein folding, DNA replication, and stress responses. They are also implicated in a number of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

LOC105376627 is of particular interest as a potential drug target or biomarker because of its involvement in a number of cellular processes that are associated with a variety of diseases. For example, LOC105376627 has been shown to be involved in the regulation of protein folding and in the assembly of protein-protein interfaces, which are important for the regulation of a variety of cellular processes.

In addition, LOC105376627 has also been shown to be involved in the regulation of DNA replication and in the repair of DNA damage. These processes are important for the development and progression of cancer, and LOC105376627 may be a useful biomarker for the diagnosis and treatment of cancer.

Another potential application of LOC105376627 is its involvement in stress responses. As mentioned earlier, LOC105376627 is involved in the regulation of protein folding and in the assembly of protein-protein interfaces, and these processes are important for the regulation of stress responses. This suggests that LOC105376627 may be a useful target for drugs that are designed to modulate protein folding and protein-protein interface formation in response to stress.

LOC105376627 is also of interest as a potential drug target because of its involvement in the regulation of cellular processes that are important for the development and progression of neurodegenerative disorders. For example, LOC105376627 has been shown to be involved in the regulation of protein folding and in the assembly of protein-protein interfaces, which are important for the regulation of the structure and function of proteins. This suggests that LOC105376627 may be a useful target for drugs that are designed to modulate protein folding and protein-protein interface formation in response to neurodegenerative disorders.

In conclusion, LOC105376627 is a protein that is expressed in a variety of tissues and cells in the human body and is involved in a number of cellular processes that are important for the development and progression of a variety of diseases. As a potential drug target or biomarker, LOC105376627 is of particular interest due to its involvement in the regulation of protein folding, DNA replication, stress responses, and cellular processes that are important for the development and progression of a variety of neurodegenerative disorders. Further research is needed to determine the full role of LOC105376627 in these processes and to develop drugs that can modulate its function.

Protein Name: Uncharacterized LOC105376627

The "LOC105376627 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376627 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730